- Home
- CMMB vs NRT Comparison
CMMB vs NRT Comparison
Compare CMMB & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- NRT
- Stock Information
- Founded
- CMMB 2004
- NRT 1975
- Country
- CMMB Israel
- NRT United States
- Employees
- CMMB N/A
- NRT N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- NRT Oil & Gas Production
- Sector
- CMMB Health Care
- NRT Energy
- Exchange
- CMMB Nasdaq
- NRT Nasdaq
- Market Cap
- CMMB 32.2M
- NRT 44.0M
- IPO Year
- CMMB N/A
- NRT N/A
- Fundamental
- Price
- CMMB $1.71
- NRT $4.66
- Analyst Decision
- CMMB Strong Buy
- NRT
- Analyst Count
- CMMB 2
- NRT 0
- Target Price
- CMMB $9.00
- NRT N/A
- AVG Volume (30 Days)
- CMMB 835.3K
- NRT 32.1K
- Earning Date
- CMMB 03-06-2025
- NRT 03-04-2025
- Dividend Yield
- CMMB N/A
- NRT 10.09%
- EPS Growth
- CMMB N/A
- NRT N/A
- EPS
- CMMB N/A
- NRT 0.55
- Revenue
- CMMB N/A
- NRT $5,855,685.00
- Revenue This Year
- CMMB N/A
- NRT N/A
- Revenue Next Year
- CMMB N/A
- NRT N/A
- P/E Ratio
- CMMB N/A
- NRT $8.47
- Revenue Growth
- CMMB N/A
- NRT N/A
- 52 Week Low
- CMMB $0.58
- NRT $3.88
- 52 Week High
- CMMB $2.55
- NRT $8.62
- Technical
- Relative Strength Index (RSI)
- CMMB 32.89
- NRT 47.50
- Support Level
- CMMB $1.66
- NRT $4.71
- Resistance Level
- CMMB $2.06
- NRT $4.88
- Average True Range (ATR)
- CMMB 0.16
- NRT 0.27
- MACD
- CMMB -0.04
- NRT -0.03
- Stochastic Oscillator
- CMMB 9.43
- NRT 31.51
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.